Dan, G., Martinez-Rubio, A., Agewall, S., Boriani, G., Borggrefe, M., Gaita, F., . . . Martinez, F. (2018). Antiarrhythmic drugs–clinical use and clinical decision making: A consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace (London, England), 20(5), 731-732an. https://doi.org/10.1093/europace/eux373
Citácia podle Chicago (17th ed.)Dan, Gheorghe-Andrei, et al. "Antiarrhythmic Drugs–clinical Use and Clinical Decision Making: A Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, Endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)." Europace (London, England) 20, no. 5 (2018): 731-732an. https://doi.org/10.1093/europace/eux373.
Citácia podľa MLA (8th ed.)Dan, Gheorghe-Andrei, et al. "Antiarrhythmic Drugs–clinical Use and Clinical Decision Making: A Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, Endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)." Europace (London, England), vol. 20, no. 5, 2018, pp. 731-732an, https://doi.org/10.1093/europace/eux373.